Two participants in Evonik Corp.'s 401(k) plan filed a proposed class action in the District of New Jersey claiming the plan’s fiduciaries chose excessively expensive investment options without properly investigating cheaper alternatives.
The lawsuit alleges Evonik, the U.S. arm of German specialty chemical company
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
